Luoyang Putai Biotech Co., Ltd., Luoyang, China.
Luoyang Zhongke Biochip Technology Co., Ltd., Luoyang, China.
Front Cell Infect Microbiol. 2022 Jul 26;12:912108. doi: 10.3389/fcimb.2022.912108. eCollection 2022.
Pseudorabies caused by pseudorabies virus (PRV) infection is still a major disease affecting the pig industry; its eradication depends on effective vaccination and antibody (Ab) detection. For a more rapid and accurate PRV detection method that is suitable for clinical application, here, we established a poly(dimethylsiloxane)-based (efficient removal of non-specific binding) solid-phase protein chip platform (blocking ELISA) for dual detection of PRV gD and gE Abs. The purified gD and gE proteins expressed in baculovirus were coated into the highly hydrophobic nanomembrane by an automatic spotter, and the gray values measured by a scanner were used for the S/N (sample/negative) value calculation (gD and gE Abs standard, positive: S/N value ≤0.6; negative: S/N value >0.7; suspicious: 0.6 < S/N ≤ 0.7). The method showed an equal sensitivity in the gD Ab test of immunized pig serum samples compared to the neutralization test and higher sensitivity in the gE Ab test compared to the commercial gE Ab detection kit. In the clinical evaluation, we found an agreement of 100% (122/122) in the gD Ab detection compared to the neutralization test and an agreement of 97.5% (119/122) in the gE Ab detection compared to the commercial PRV gE Ab detection kit. In summary, the protein chip platform for dual detection of PRV gD and gE Abs showed high sensitivity and specificity, which is suitable for PRV immune efficacy evaluation and epidemic monitoring.
由伪狂犬病病毒 (PRV) 感染引起的伪狂犬病仍然是影响养猪业的主要疾病;其根除取决于有效的疫苗接种和抗体 (Ab) 检测。为了建立一种更快速、更准确、更适合临床应用的 PRV 检测方法,我们在这里建立了一种基于聚二甲基硅氧烷的 (有效去除非特异性结合) 固相蛋白芯片平台 (阻断 ELISA),用于双重检测 PRV gD 和 gE Ab。用自动点样仪将在杆状病毒中表达的纯化 gD 和 gE 蛋白包被到高度疏水性纳米膜中,并用扫描仪测量的灰度值用于 S/N (样品/阴性) 值计算 (gD 和 gE Ab 标准,阳性: S/N 值≤0.6;阴性: S/N 值>0.7;可疑: 0.6< S/N ≤ 0.7)。该方法在免疫猪血清样品的 gD Ab 检测中与中和试验具有同等的敏感性,在 gE Ab 检测中比商业 gE Ab 检测试剂盒具有更高的敏感性。在临床评估中,我们发现与中和试验相比,gD Ab 检测的一致性为 100%(122/122),与商业 PRV gE Ab 检测试剂盒相比,gE Ab 检测的一致性为 97.5%(119/122)。总之,用于双重检测 PRV gD 和 gE Ab 的蛋白芯片平台显示出高灵敏度和特异性,适用于 PRV 免疫效果评估和流行监测。